Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE
Yubrine Moraa Gachemba, Consultant Cardiologist at The Nairobi Hospital, shared EuroIntervention‘s post on LinkedIn:
“Pulmonary embolism care is entering a more nuanced era.
BETULA adds important randomized evidence that carefully selected patients with intermediate-high-risk PE may achieve earlier right ventricular unloading with low-dose, short-duration catheter-directed thrombolysis, without an observed increase in major bleeding.
But the larger question is not simply whether we can intervene earlier. It is which patients derive meaningful clinical benefit, at what risk, and within which health systems.
For Africa and the wider Global South, this matters enormously. Innovation in PE care must be accompanied by better risk stratification, multidisciplinary decision-making, appropriate imaging, and equitable access to reperfusion strategies.
The future of PE management will not be anticoagulation versus intervention. It will be precision in selecting the right patient, for the right therapy, at the right time.
Important data – and an evolving space to watch.”
EuroIntervention shared a post on LinkedIn about a recent article by Jacob Schultz et al., adding:
“In the randomised BETULA trial, low-dose, short-duration catheter-directed thrombolysis improved early right ventricular unloading compared with anticoagulation alone in patients with intermediate-high-risk pulmonary embolism, without increasing major bleeding.”
Title: Low-dose, short-duration catheter-directed thrombolysis for acute intermediate-high-risk pulmonary embolism: the BETULA trial
Authors: Jacob Schultz, Gro Egholm, Mikael Kjær Poulsen, Bo Løfgren, Morten Würtz, Hanne Maare Søndergaard, Mads Jønsson Andersen, Jacob Valentin Hansen, Gratien Andersen, Shifan Thangavel, Søren Mellemkjær, Anushree Burade, Mannudeep Kalra, Jens Erik Nielsen-Kudsk, Asger Andersen
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 21, 2026, 16:57Fabrice Cognasse: Celebrating the Next Generation of Platelet Research and Transfusion Medicine
-
Oct 21, 2026, 16:47Christabel Odeta: Treating Pediatric Cancer in Children With Sickle Cell Disease
-
Oct 21, 2026, 16:36Sharlene Haywood: Bringing Multidisciplinary Learning Into Nursing Practice
-
Oct 21, 2026, 16:19Vanessa Carvalho: New Research on Platelet-Derived Extracellular Vesicles in Preeclampsia
-
Oct 21, 2026, 15:41Women and Hemostasis Across Hormonal Transition
-
Oct 21, 2026, 15:35Danny Hsu: Pharma’s 2025 Blockbusters Through a Hematologist’s Lens
-
Oct 21, 2026, 15:12Yue Zhang: Flow Cytometry for Translational Immunology and Cancer Research
-
Oct 21, 2026, 14:58Radoš Stefanović: How Red Blood Cells Adapt After Exercise
-
Oct 21, 2026, 14:08Vera Ghali: The Role of Hepcidin Assays in Diagnosing Iron Disorders